These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. van Schayck OC, Haughney J, Aubier M, Selroos O, Ekström T, Ostinelli J, Buhl R. Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455 [Abstract] [Full Text] [Related]
32. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China. Fu WP, Zhao ZH, Zhong L, Sun C, Fang LZ, Liu L, Zhang JQ, Wang L, Shu JK, Wang XM, Dai LM. Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278 [Abstract] [Full Text] [Related]
36. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study. Saito T, Hasunuma T. Clin Drug Investig; 2012 Jan 01; 32(1):51-61. PubMed ID: 22024920 [Abstract] [Full Text] [Related]
37. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Lancet; 1997 Oct 04; 350(9083):995-9. PubMed ID: 9329515 [Abstract] [Full Text] [Related]
38. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. Slob EMA, Vijverberg SJH, Palmer CNA, Zazuli Z, Farzan N, Oliveri NMB, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH. Pediatr Allergy Immunol; 2018 Nov 04; 29(7):705-714. PubMed ID: 29992699 [Abstract] [Full Text] [Related]